Direktorat Registrasi ObatValid

SIMVASTATIN

Claim this product
BPOM Number
GKL0332709017A1
Approved
13 June 2026
Expiry
2 June 2027
Form
TABLET SALUT SELAPUT

About This Registration

SIMVASTATIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0332709017A1. Its current registration status is Valid, with the licence valid until 2 June 2027. The product is registered to YARINDO FARMATAMA and manufactured by YARINDO FARMATAMA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

SIMVASTATIN

Market Intelligence

Owner Portfolio
YARINDO FARMATAMA holds 137 BPOM registrations
Manufacturer Scale
YARINDO FARMATAMA - INDONESIA produces 128 registered products
Registration Age
Registered for 2 months
Expiry Status
Expires in 9 months
Update Status
Recently updated (80 days ago)

FDA Cross-Reference

via openFDA
Generic Name
SIMVASTATIN
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from YARINDO FARMATAMA

GLUDEPATIC 500

-DKL2632724417A1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717B1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

ARIPIPRAZOLE

-GKL2532723035A2
Valid
Approved: Dec 31, 2025CAIRAN ORAL
View product →

VERDON

-DKL2532723917A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

ZENDIAB

-DKL9827910517A1
Valid
Approved: Jul 27, 2026TABLET SALUT SELAPUT
PABRIK PHARMASI ZENITH - INDONESIA
View product →

DUPHALAC

-DBI1381601737A2
Valid
Approved: Jun 15, 2026SIRUP
ABBOTT INDONESIA - INDONESIA
View product →

LETHIRA

-DKL1221641417B1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
PHAROS INDONESIA - INDONESIA
View product →

STESOLID

-DPL7405505437A1
Valid
Approved: Feb 12, 2026SIRUP
ACTAVIS INDONESIA - INDONESIA
View product →

PROVE C-1000

-DKL2011646343A1
Valid
Approved: Dec 21, 2025INJEKSI
KALBE FARMA - INDONESIA
View product →
1